These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy. Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1. Sun J; Zhang H; Li L; Yu L; Fu L Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912 [TBL] [Abstract][Full Text] [Related]
5. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression. Fu J; Wu B; Zhong S; Deng W; Lin F Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600 [TBL] [Abstract][Full Text] [Related]
6. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver. Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586 [TBL] [Abstract][Full Text] [Related]
7. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis. Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413 [TBL] [Abstract][Full Text] [Related]
8. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a. Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384 [TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0009096/miR-370-3p modulates hepatic stellate cell proliferation and fibrosis during biliary atresia pathogenesis. Wu Z; Wang B; Chen S; Zuo T; Zhang W; Cheng Z; Fu J; Gong J PeerJ; 2024; 12():e17356. PubMed ID: 38766485 [TBL] [Abstract][Full Text] [Related]
10. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells. Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448 [TBL] [Abstract][Full Text] [Related]
11. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2. Yu F; Chen B; Fan X; Li G; Dong P; Zheng J Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway. Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152 [TBL] [Abstract][Full Text] [Related]
13. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells. Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367 [TBL] [Abstract][Full Text] [Related]
14. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways. Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452 [TBL] [Abstract][Full Text] [Related]
15. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling. Wu SM; Li TH; Yun H; Ai HW; Zhang KH Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340 [TBL] [Abstract][Full Text] [Related]
16. miR-374a/Myc axis modulates iron overload-induced production of ROS and the activation of hepatic stellate cells via TGF-β1 and IL-6. Yuan Q; Zhang Z; Hu X; Liao J; Kuang J Biochem Biophys Res Commun; 2019 Jul; 515(3):499-504. PubMed ID: 31171361 [TBL] [Abstract][Full Text] [Related]
17. A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-β1/Smads pathway. Zhang R; Wang M; Lu H; Wang J; Han X; Liu Z; Li L; Li M; Tian X; Chen S; Zhang G; Xiong Y; Li J Adv Clin Exp Med; 2023 Apr; 32(4):469-479. PubMed ID: 36413180 [TBL] [Abstract][Full Text] [Related]
18. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression. Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic control of mitochondrial fission enables hepatic stellate cells activation in liver fibrosis via PGC-1α-Drp1 pathway. Yang JJ; Wang J; Yang Y; Sun F; Yang Y; Li J; Tao H; Lu C Mitochondrion; 2022 Sep; 66():38-50. PubMed ID: 35905890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]